🔗 Permalink

Inventor profile of:

Peter Olson

City:

San Diego, California

Country:

United States

Published Applications:

Last publication date:

2026-04-16

Top Assignees for applications by Peter Olson

The entities that hold a legal rights for patent applications filed by inventor Olson Peter:

MIRATI THERAPEUTICS, INC. 14 Princeton, NJ United States
Mirati Therapeutics, Inc. 2 San Diego, CA United States

Recent patent applications by Olson Peter

Peter Olson from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-16

US20260102401A1

Human necessities

Combination Therapies

#2 | 2026-04-09

US20260097038A1

Human necessities

COMPOSITIONS OF ADAGRASIB AND mTOR INHIBITORS AND METHODS OF TREATMENT THEREWITH

#3 | 2025-10-09

US20250312351A1

Human necessities

COMBINATION THERAPIES USING PRMT5 INHIBITORS AND SOS1 INHIBITORS FOR THE TREATMENT OF CANCER

#4 | 2025-10-09

US20250312344A1

Human necessities

COMBINATION THERAPIES USING PRMT5 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER

#5 | 2025-10-09

US20250312343A1

Human necessities

COMBINATION THERAPIES USING PRMT5 INHIBITORS AND KRAS G12D INHIBITORS FOR THE TREATMENT OF CANCER

#6 | 2025-08-21

US20250262213A1

Human necessities

COMBINATION THERAPIES

#7 | 2025-08-07

US20250249003A1

Human necessities

COMBINATIONS OF KRAS G12D INHIBITORS WITH IRINOTECAN AND RELATED METHODS OF TREATMENT

#8 | 2025-07-03

US20250213579A1

Human necessities

COMBINATION THERAPIES

#9 | 2025-04-03

US20250108055A1

Human necessities

COMBINATION THERAPIES

#10 | 2025-03-06

US20250073241A1

Human necessities

Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer

#11 | 2025-01-02

US20250000863A1

Human necessities

COMBINATION THERAPIES OF KRAS G12D INHIBITORS WITH SOS1 INHIBITORS

#12 | 2024-12-26

US20240423987A1

Human necessities

Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer

#13 | 2024-12-26

US20240423984A1

Human necessities

COMBINATION THERAPIES OF KRAS G12D INHIBITORS WITH SHP-2 INHIBITORS

#14 | 2024-12-12

US20240408099A1

Human necessities

COMBINATION THERAPIES OF KRAS G12D INHIBITORS WITH Pan ErbB FAMILY INHIBITORS

#15 | 2024-12-12

US20240408098A1

Human necessities

COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT

#16 | 2024-12-05

US20240398795A1

Human necessities

COMBINATION THERAPIES USING PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER

#17 | 2024-05-16

US20240156821A1

Human necessities

COMBINATION THERAPIES

#18 | 2022-10-20

US20220331324A1

Human necessities

Combination therapies using PRMT5 inhibitors for the treatment of cancer

#19 | 2022-10-20

US20220331323A1

Human necessities

Combination therapies using PRMT5 inhibitors for the treatment of cancer

#20 | 2022-03-31

US20220096482A1

Human necessities

COMBINATION THERAPIES

#21 | 2022-03-17

US20220079947A1

Human necessities

COMBINATION THERAPIES

#22 | 2022-02-24

US20220054492A1

Human necessities

Combination therapies

#23 | 2022-02-24

US20220054491A1

Human necessities

COMBINATION THERAPIES

#24 | 2022-02-10

US20220040182A1

Human necessities

COMBINATION THERAPIES

#25 | 2022-02-10

US20220040181A1

Human necessities

COMBINATION THERAPIES

#26 | 2021-03-25

US20210085683A1

Human necessities

Combination therapies

InventorID:

5319049 ⎘